Original articles

• Cost-effectiveness of Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain

  José R. González-Juanatey, José Álvarez-Sabin, José M. Lobos, Antoni Martínez-Rubio, Joan C. Reverter, Itziar Oyagüez, Nuria González-Rojas, Virginia Becerra

  Rev Esp Cardiol. 2012;65:901-10

• Myocardial Bridging Assessed by Multidetector Computed Tomography: Likely Cause of Chest Pain in Younger Patients With Low Prevalence of Dyslipidemia

  José Alberto de Agustín, Pedro Marcos-Alberca, Covadonga Fernández-Golfín, Sara Bordes, Gisela Feltes, Carlos Almería, José Luis Rodrigo, Juan Arrazola, Leopoldo Pérez de Isla, Carlos Macaya, José Zamorano

  Rev Esp Cardiol. 2012;65:885-90

• Impact on Delay Times and Characteristics of Patients Undergoing Primary Percutaneous Coronary Intervention in the Southern Metropolitan Area of Barcelona After Implementation of the Infarction Code Program

  Joan Antoni Gómez-Hospital, Paolo Domenico Dallaglio, Jose Carlos Sánchez-Salado, Albert Ariza, Silvia Homs, Victoria Lorente, Jose Luis Ferreiro, Josep Gomez-Lara, Rafael Romaguera, Joel Salazar-Mendiguchía, Luis Teruel, Ángel Cequier

  Rev Esp Cardiol. 2012;65:911-8

• Reassessment of Blood Culture-Negative Endocarditis: Its Profile Is Similar to That of Blood Culture-Positive Endocarditis

  Carlos Ferrera, Isidre Vilacosta, Cristina Fernández, Javier López, Carmen Olmos, Cristina Sarriá, Ana Revilla, David Vivas, Carmen Sáez, Enrique Rodríguez, José Alberto San Román

  Rev Esp Cardiol. 2012;65:891-900

• LRP1 Gene Polymorphisms Are Associated With Premature Risk of Cardiovascular Disease in Patients With Familial Hypercholesterolemia

  Rosa Aledo, Rodrigo Alonso, Pedro Mata, Vicenta Llorente-Cortés, Teresa Padró, Lina Badimon

  Rev Esp Cardiol. 2012;65:807-12

• Aortic Valve-derived Calcifyng Nanoparticles, No Evidence of Life

  Ignasi Barba, Eduardo Villacorta, Miguel-Angel Bratos-Perez, Maria Antolín, Encarna Varela, Pedro Luís Sanchez, Pilar Tornos, David Garcia-Dorado

  Rev Esp Cardiol. 2012;65:813-8

• Cross-sectional Study of Cardiac Resynchronization Therapy in Spain. Indications. Implant Techniques. Optimization and Follow-up

  Antonio Hernández-Madrid, Roberto Matía Francés, Concepción Moro, José Zamorano, Luis Almenar, Maria José Sancho-Tello de Carranza, Ignacio Fernández Lozano

  Rev Esp Cardiol. 2012;65:826-34

• Inflammation and Apoptosis in Hypertension. Relevance of the Extent of Target Organ Damage

  Pedro Morillas, Helder de Andrade, Jesus Castillo, Juan Quiles, Vicente Bertomeu-González, Alberto Cordero, Estefanía Tarazón, Esther Roselló, Manuel Portolés, Miguel Rivera, Vicente Bertomeu-Martínez

  Rev Esp Cardiol. 2012;65:819-25

• Analysis of Judgments in the Practice of Cardiology Resolved on Appeal in Spain Between 1992 and 2007

  Andrés Santiago-Sáez, Bernardo Perea-Pérez, Maria Elena Albarrán-Juan, Elena Labajo-González, María José Anadón-Baselga, Jesus Almendral-Garrote

  Rev Esp Cardiol. 2012;65:801-6

• Evolution and Mortality Risk Factors in Children With Continuous Renal Replacement Therapy After Cardiac Surgery

  Maria J. Santiago, Jesús López-Herce, Javier Urbano, Maria José Solana, Jimena del Castillo, Amelia Sánchez, Jose M. Bellón

  Rev Esp Cardiol. 2012;65:795-800

• Anticoagulation Therapy in Patients With Heart Failure Due to Systolic Dysfunction and Sinus Rhythm, Analysis of REDINSCOR Registry

  Patricia Avellana, Javier Segovia, Andreu Ferrero, Rafael Vázquez, Josep Brugada, Xavier Borrás, Luis Alonso-Pulpón, Juan Cinca

  Rev Esp Cardiol. 2012;65:705-12

• Utilization of Evidence-based Cardiovascular Therapies and Achievement of Therapeutic Goals in Patients With Peripheral Artery Disease

  José M. Mostaza, Enrique Puras, Mariano Blasco, Carlos Lahoz, María L. Samaniego

  Rev Esp Cardiol. 2012;65:713-8

• Prevalence and Clinical Characteristics of Peripheral Arterial Disease in the Study Population Hermex

  Francisco J. Félix-Redondo, Daniel Fernández-Bergés, María Grau, José M. Baena-Diez, José M. Mostaza, Joan Vila

  Rev Esp Cardiol. 2012;65:726-33

• Attitude and Efficacy of Cardiologists With Respect to Smoking in Patients After Acute Coronary Syndromes

  Alberto Cordero, Vicente Bertomeu-Martínez, Pilar Mazón, Juan Cosín, Enrique Galve, Iñaki Lekuona, Fernando de la Guía, José Ramón Gonzalez-Juanatey

  Rev Esp Cardiol. 2012;65:719-25

• In-hospital Acquired Anemia in Acute Coronary Syndrome. Predictors. In-hospital Prognosis and One-year Mortality

  Oona Meroño, Mercé Cladellas, Lluis Recasens, Cosme Garcia-Garcia, Núria Ribas, Victor Bazan, Núria Farré, Álvaro Sainz, Josep Comin, Jordi Bruguera

  Rev Esp Cardiol. 2012;65:742-8

• Stable Angina in Spain and its Impact on Quality of Life. The AVANCE Registry

  Xavier Borrás, Xavier Garcia-Moll, Juan José Gómez-Doblas, Antonio Zapata, Remei Artigas

  Rev Esp Cardiol. 2012;65:734-41

• Identification and Bibliometric Characterization of Research Groups in the Cardio-Cerebrovascular Field, Spain 1996-2004

  Raúl I. Méndez-Vásquez, Eduard Suñén-Pinyol, Rosa Cervelló, Jordi Camí

  Rev Esp Cardiol. 2012;65:642-50

• Red Blood Cell Distribution Width Adds Prognostic Value for Outpatients With Chronic Heart Failure

  Juan C. Bonaque, Domingo A. Pascual-Figal, Sergio Manzano-Fernández, Cristina González-Cánovas, Alfredo Vidal, Carmen Muñoz-Esparza, Iris P. Garrido, Francisco Pastor-Pérez, Mariano Valdés

  Rev Esp Cardiol. 2012;65:606-12

• Rapid Point-of-Care NT-proBNP Optimal Cut-off Point for Heart Failure Diagnosis in Primary Care

  José M. Verdú, Josep Comín-Colet, Mar Domingo, Josep Lupón, Miguel Gómez, Luis Molina, Jose M. Casacuberta, Miguel A. Muñoz, Amparo Mena, Jordi Bruguera-Cortada

  Rev Esp Cardiol. 2012;65:613-9

• Predictive Value of the CHA 2DS 2-VASc Score in Atrial Fibrillation Patients at High Risk for Stroke Despite Oral Anticoagulation

  Eva Jover, Vanessa Roldán, Pilar Gallego, Diana Hernández-Romero, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Francisco Marín

  Rev Esp Cardiol. 2012;65:627-33